UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
In need of quick funds? Discover ways to get cash instantly from bank services to meet your urgent needs.
21,071 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A major insider sale at LegalZoom prompts questions for investors. This guide breaks down what the move could mean, h...
Fresh money data in 2026 contests one core debt strategy from Dave Ramsey, while underscoring the value of discipline...
Big tech is pouring hundreds of billions into AI infrastructure. This creates opportunities for selective stocks. Lea...
Investors are weighing whether HOOD deserves a place in a modern portfolio. This guide helps you gauge signals, risks...
Ferrari delivered a quarter that topped estimates, yet the stock moved lower. This piece deciphers what drove the bea...
Investors weighed the promise of Milestone Pharmaceuticals against the realities of a high-stakes biotech market. Thi...
When a top investor takes a sizable stake in a marquee stock, it grabs attention. This piece breaks down what billion...
A handful of iconic dividend payers have fallen this year, but market watchers see potential upside as earnings stay ...
Oracle delivered a dramatic rise in May as it pivots toward AI cloud infrastructure. This article breaks down the dri...
June markets stay choppy as Aurora Innovation slides on Uber stake actions. This guide breaks down what it means for ...
Bitmine expands its Ethereum treasury with a $135 million ETH buy, bringing holdings toward a 5% share of the total s...